Does Olsalazine Sodium Interact with Low Molecular Weight Heparin?
Olsalazine Sodium and Low Molecular Weight Heparin have a major drug interaction according to U.S. FDA drug labeling data. Co-administration may increase risk of bleeding and hematomas following neuraxial anesthesia. Discontinue olsalazine prior to initiation or monitor closely. The mechanism involves increased bleeding risk. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Olsalazine Sodium and Low Molecular Weight Heparin occurs because increased bleeding risk. Clinically, this means co-administration may increase risk of bleeding and hematomas following neuraxial anesthesia. discontinue olsalazine prior to initiation or monitor closely. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Olsalazine Sodium and your doctor is considering prescribing Low Molecular Weight Heparin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider